Serum pancreolauryl: non invasive biochemical test for evaluation of the exocrine pancreatic function

被引:0
|
作者
Lopez Mingorance, Fabiana Norma [1 ]
Manuel Tiscornia, Osvaldo [1 ]
Alberto Negri, Gustavo [1 ]
Beatriz Di Carlo, Maria [1 ]
机构
[1] Univ Buenos Aires, Hosp Clin Jose de San Martin, Programa Estudios Pancreat,Fac Farm & Bioquim, Dpto Bioquim Clin,Inst Fisiopatol & Bioquim Clin, RA-1053 Buenos Aires, DF, Argentina
来源
ACTA BIOQUIMICA CLINICA LATINOAMERICANA | 2011年 / 45卷 / 04期
关键词
pancreolauryl test; chronic pancreatitis; pancreopathy; pancreatic cholesterol esterase; fluorescein dilaureate; SECRETORY FUNCTION; FLUORESCEIN; DIAGNOSIS; INSULIN; PABA;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The pancreas is a mixed gland; the exocrine portion produces and secretes enzymes involved in the digestion of nutrients in the diet. Chronic pancreatitis (CP) is an inflammatory process that leads to progressive loss of the functions of the gland. The diagnosis is based on a clinical study, imaging and laboratory. Serum pancreolauryl test (PLT) indirectly measures the ctivity of a specific pancreatic cholesterol esterase. The objectives of the present work are to optimize the PLTs, to establish sex differences in PLT values, and to study the PL values ?? in CP and control patients. The cutoff value used for the PLT was 4.5 mg/L. In patients with CP the cutoff value was lower than the control (p<0.001), and established differences between moderate and severe CP. The PLT was lower in men than in women (p<0.05). PLT is an economic, noninvasive and feasible test to perform in the biochemical laboratory.
引用
收藏
页码:721 / 725
页数:5
相关论文
共 35 条
  • [31] Non-invasive Evaluation of NAFLD with Indocyanine Green Clearance Test: a Preliminary Study in Morbidly Obese Patients Undergoing Bariatric Surgery
    Pierre Eric Danin
    Rodolphe Anty
    Stephanie Patouraux
    Marc Raucoules-Aimé
    Jean Gugenheim
    Albert Tran
    Philippe Gual
    Antonio Iannelli
    Obesity Surgery, 2018, 28 : 735 - 742
  • [32] Performance Evaluation of a Novel Non-Invasive Test for the Detection of Advanced Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease
    Stefanska, Anna
    Bergmann, Katarzyna
    Suwala, Szymon
    Mankowska-Cyl, Aneta
    Kozinski, Marek
    Junik, Roman
    Krintus, Magdalena
    Panteghini, Mauro
    METABOLITES, 2024, 14 (01)
  • [33] A Novel, non-invasive Test Enabling Bladder Cancer Detection in Urine Sediment of Patients Presenting with Haematuria-A Prospective Multicentre Performance Evaluation of ADXBLADDER
    Dudderidge, Tim
    Stockley, Jacqui
    Nabi, Ghulam
    Mom, Jaswant
    Umez-Eronini, Nkemi
    Hrouda, David
    Cresswell, Jo
    McCracken, Stuart Robert Crozier
    EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (01): : 42 - 46
  • [34] Evaluation of serum fibronectin levels and fibronectin gene polymorphism in patients receiving intravesical BCG therapy for non-muscle invasive bladder cancer and its prognostic value
    Nebioglu, Ali
    Tanriverdi, Rojda
    Basaranoglu, Mert
    Saylam, Baris
    Ulusoy, Ercument
    Bozlu, Murat
    Akbay, Erdem
    Tamer, Lulufer
    Erdogan, Semra
    BMC UROLOGY, 2024, 24 (01):
  • [35] Cost-effectiveness of adding a non-invasive acoustic rule-out test in the evaluation of patients with symptoms suggestive of coronary artery disease: rationale and design of the prospective, randomised, controlled, parallel-group multicenter FILTER-SCAD trial
    Bjerking, Louise Hougesen
    Hansen, Kim Wadt
    Biering-Sorensen, Tor
    Bronnum-Schou, Jens
    Engblom, Henrik
    Erlinge, David
    Haahr-Pedersen, Sune Ammentorp
    Heitmann, Merete
    Hove, Jens Dahlgaard
    Jensen, Magnus Thorsten
    Kruse, Marie
    Rader, Sune
    Strange, Soren
    Galatius, Soren
    Prescott, Eva Irene Bossano
    BMJ OPEN, 2021, 11 (08):